GLP‑1 medicines such as semaglutide and tirzepatide have become very popular for weight loss. They have changed how doctors think about obesity, but they are only one piece of the puzzle.
Experts have updated the POWER guide, a plan first released in 2017 for obesity care. The new version adds recent advances like powerful weight‑loss drugs, newer endoscopic procedures, more use of bariatric surgery, and the rise of precision medicine.
Obesity Is Seen as a Chronic Disease
The update introduces the idea of “clinical obesity.” This view treats obesity as a long‑term illness that can affect many parts of the body. It also reminds doctors that body‑mass index (BMI) alone does not tell the whole health story.
A Team Approach Works Best
Today, treatment often involves a team of specialists. Medications, endoscopic tools, and surgery are no longer separate options. Instead, doctors mix and match them to fit each patient.
Endoscopic Options Gain Support
New studies show that endoscopic bariatric therapies, such as endoscopic sleeve gastroplasty, can help people lose weight safely.
Combining Treatments Improves Results
Research suggests that pairing GLP‑1 drugs with an endoscopic procedure or bariatric surgery can lead to bigger and longer‑lasting weight loss than using any single method.
Gastroenterologists Play a Key Role
Doctors who specialize in the digestive system, including gastroenterologists and hepatologists, are important in managing obesity and the health problems that come with it.